Optic neuritis – general overview with particular emphasis on differential diagnosis
DOI:
https://doi.org/10.12775/QS.2024.18.53757Keywords
atypical optic neuritis, typical optic neuritis, retrobulbar optic neuritis, multiple sclerosis, MOGAD, ON, NMO, NMOSDAbstract
Introduction and purpose
Optic neuritis (ON), especially retrobulbar, is a common inflammatory neuropathy of the optic nerve occurring typically in young adults. This neuro-ophthalmological condition is involved in the clinical picture of multiple diseases and may be frequently a heralding symptom of them [1,2,3,4,5,7,13].
The main aim of this review is to provide clinicians with thorough information on the possible etiologies of ON, its differentiation and management.
Review Methods
For this report, we conducted a research of the available, most recent literature in Pubmed and medical books using the keywords (below). As a result, we included over 30 articles and chapters as a benchmark of our analysis.
A brief description of the State of Knowledge
Optic neuritis is a frequent manifestation of many diseases, with a particular focus on demyelinating processes [1,2,3,4,5,7,13]. Its incidence in central Europe is about 5 per 100 000 people per year [26]. Although the symptoms may be very severe including even abrupt vision loss or intense pain on ocular movement, the prognosis regarding future visual acuity is generally good [1,2,9]. In contrast, the spectrum of diseases underlying optic neuritis is much more diverse [9,10,13,25].
Summary
Although a definite diagnosis is not always possible when looking for the cause of ON, it is crucial to know the possible etiologies and to differentiate them as much as we can by means of commonly used tools. In this way, a correct diagnosis will lead to earlier, more personalized treatment and a better overall prognosis [1,5,9,10,11,15,25].
References
Benard-Seguin E, Costello F. Optic neuritis: current challenges in diagnosis and management. Current Opinion in Neurology. 2023;36(1):10. doi:10.1097/WCO.0000000000001128
Bennett JL, Costello F, Chen JJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. The Lancet Neurology. 2023;22(1):89-100. doi:10.1016/S1474-4422(22)00187-9
Kraker JA, Chen JJ. An update on optic neuritis. J Neurol. 2023;270(10):5113-5126. doi:10.1007/s00415-023-11920-x
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography - PMC. Accessed July 4, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425816/
Niżankowska M.H. Ophthalmology. The clinical basis. Medical Publishing House PZWL, Warsaw 2007. Chapter 14., pages 478-479. (Polish)
Hoorbakht H, Bagherkashi F. Optic neuritis, its differential diagnosis and management. Open Ophthalmol J. 2012;6:65-72. doi: 10.2174/1874364101206010065. Epub 2012 Jul 24. PMID: 22888383; PMCID: PMC3414716.
Grzybowski A. Ophthalmology. Edra Urban & Partner, Wroclaw 2020. Chapter 23., pages 228-229. (Polish)
Byszewska A., Rękas M. BCSC Basic and Clinical Science Course 5. Neuroophthalmology. Edra Urban & Partners, Wroclaw 2022. Pages 116-118. (Polish)
Pane A., Burdon M.A., Miller N.R. Neuroophthalmology. Edra Urban & Partners, Wroclaw 2009. Chapter 2, pages 36, 41-45. (Polish)
Whitcher J.P., Riordan-Eva P. Vaughan and Asbury’s Ophthalmology. Czelej Publishing Company, Lublin 2011. Chapter 14., pages 264-272. (Polish)
Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis - PMC. Accessed July 4, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456305/
Optic neuritis – causes, symptoms, treatment. Academic Ophthalmology. Accessed July 4, 2024. https://okulistykaakademicka.pl/leczymy/zapalenie-nerwu-wzrokowego/ (Polish)
Jamali Dogahe S, Pakravan P, Pakravan M. Acute Optic Neuritis: An Update on Approach and Management. J Ophthalmic Vis Res. 2023;18(4):433-440. doi:10.18502/jovr.v18i4.14556
Bowling B., Kanski’s Clinical Ophthalmology, 8th ed. by Szaflik J., Izdebska J. Edra Urban & Partner, Wroclaw 2017. Chapter 19., pages 779-786. (Polish)
Ojha PT, Barvalia PP, Singh R, et al. Atypical Optic Neuritis: The Potential Red Flags. Neurology India. 2022;70(5):1982. doi:10.4103/0028-3886.359189
Greco G, Colombo E, Gastaldi M, et al. Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis. Int J Mol Sci. 2023;24(21):15986. doi:10.3390/ijms242115986
Kaźmierczak K, Malukiewicz-Wiśniewska G. Retrobulbar optic neuritis
and multiple sclerosis. Klinika Oczna / Acta Ophthalmologica Polonica. 2006;108(3):285-289. (Polish)
Osborne BJ, Volpe NJ. Optic neuritis and risk of MS: Differential diagnosis and management. CCJM. 2009;76(3):181-190. doi:10.3949/ccjm.76a.07268
Pan S, Podemski R, Naczelny R. Expanded Disability Status Scale; EDSS) — according to J. Kurtzke. Polish Neurological Review. 2017;13(1):32-35. (Polish)
Kozubski W. Neurology. Compendium. Medical Publishing House PZWL, Warsaw 2019. Chapter 18., pages 373-391. (Polish)
Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. The Lancet Neurology. 2022;21(12):1120-1134. doi:10.1016/S1474-4422(22)00200-9
Sarkar P, Mehtani A, Gandhi HC, Dubey V, Tembhurde PM, Gupta MK. Atypical optic neuritis: An overview. Indian J Ophthalmol. 2021;69(1):27-35. doi:10.4103/ijo.IJO_451_20
Sąsiadek M, Katulska K, Majos A, et al. Guidelines of the Polish Medical Society of radiology for the routinely used MRI protocol in patients with multiple sclerosis. Polish Neurology and Neurosurgery. 2018;52(6):638-642. doi:10.1016/j.pjnns.2018.09.010 (Polish)
Selmaj K. Multiple sclerosis — diagnostic criteria and natural course of the disease. Polish Neurological Review, 2005;1(3):99-105. (Polish)
Spillers NJ, Luther PM, Talbot NC, et al. A Comparative Review of Typical and Atypical Optic Neuritis: Advancements in Treatments, Diagnostics, and Prognosis. Cureus. 16(3):e56094. doi:10.7759/cureus.56094
Wilhelm H, Schabet M. The Diagnosis and Treatment of Optic Neuritis. Dtsch Arztebl Int. 2015;112(37):616-626. doi:10.3238/arztebl.2015.0616
Gospodarczyk-Szot K, Nojszewska M, Podlecka-Piętowska A, Zakrzewska-Pniewska B. Devic neuritis and myelitis (NMO) and NMO spectrum disorders. Polish Neurological Review. 2016;12(4):196-205. (Polish)
Garg A, Margolin E, Micieli JA. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in Canada. Can J Neurol Sci. 2021;48(3):321-326. doi:10.1017/cjn.2020.201
Dorota Ł, Katarzyna S, Krystyna K. Patient in a challenging situation - diagnosed with extraocular optic neuritis in the course of multiple sclerosis. W: Krajewska-Kułak E, Łukaszuk C, Lewko J, Kułak W, red. The holistic dimension of modern medicine.
T. 3 : a collective work. ; 2017:397–412. (Polish)
Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet Neurology. 2023;22(3):268-282. doi:10.1016/S1474-4422(22)00431-8
Ambrosius W, Michalak S, Kozubski W, Kalinowska A. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management. Int J Mol Sci. 2020;22(1):100. doi:10.3390/ijms22010100
Prof. Rejdak on the treatment of Devic disease. Accessed July 4, 2024. https://www.termedia.pl/neurologia/Prof-Rejdak-o-leczeniu-choroby-Devica,47514.html (Polish)
MOGAD – a new disease entity. Accessed July 4, 2024. http://www.mp.pl/social/article/311933 (Polish)
How to diagnose and treat NMOSD? Accessed July 4, 2024. http://www.mp.pl/social/article/327135 (Polish)
Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019;15(2):89-102. doi:10.1038/s41582-018-0112-x
Matuszek P. Laboratory diagnosis of Devic disease. Euroimmun Poland. Published December 14, 2016. Accessed July 4, 2024. https://www.euroimmun.pl/diagnostyka-laboratoryjna-choroby-devica/ (Polish)
Hanson JVM, Lukas SC, Pless M, Schippling S. Optical Coherence Tomography in Multiple Sclerosis. Semin Neurol. 2016;36(2):177-184. doi:10.1055/s-0036-1582226
Dhanapalaratnam R, Markoulli M, Krishnan AV. Disorders of vision in multiple sclerosis. Clinical and Experimental Optometry. 2022;105(1):3-12. doi:10.1080/08164622.2021.1947745
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Nowak, Anita Janus, Agata Kaptur, Dawid Dziedziński, Oliwia Kwaśniewska, Dawid Łoś
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 100
Number of citations: 0